Spark Therapeutics (ONCE) Misses Q3 EPS by 6c

Spark Therapeutics (NASDAQ: ONCE) reported Q3 EPS of ($1.07), $0.06 worse than the analyst estimate of ($1.01). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $1.26 million.

For earnings history and earnings-related data on Spark Therapeutics (ONCE) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
• Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group